Akcea therapeutics stock

AKCA - Akcea Therapeutics Stock Interactive Chart ...

View the latest AKCA stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of AKCEA THERAPEUTICS, INC.. Akcea Therapeutics Learn about Akcea’s core values and hear from Akcea Canada’s Vice President & GM, Jared Rhines. Akcea Therapeutics Inc Stock Technical Analysis (AKCA ... A brief summary - strong Buy, Buy, strong Sell, Sell or Neutral signals for the Akcea Therapeutics Inc stock. A detailed technical analysis through moving averages buy/sell signals (simple and

Buy shares of Akcea Therapeutics Inc (AKCA) stock - Stash

Akcea Therapeutics | Crunchbase Oct 04, 2017 · Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc., is a development and commercialization company focused on transforming serious cardiometabolic lipid disorders. Akcea's portfolio spans multiple targets and disease states, including both rare and more common lipid disorders, using advanced RNA-targeted antisense therapeutics. Akcea Therapeutics - Stock Price History | AKCA | MacroTrends Historical daily share price chart and data for Akcea Therapeutics since 2020 adjusted for splits. The latest closing stock price for Akcea Therapeutics as of March 27, 2020 is 13.31.. The all-time high Akcea Therapeutics stock closing price was 38.99 on August 07, 2018.; The Akcea Therapeutics 52-week high stock price is 32.57, which is 144.7% above the current share price. AKCA - Akcea Therapeutics Stock Price - Barchart.com Akcea Therapeutics, Inc. is a biopharmaceutical company. It focuses on developing and commercializing drugs to treat patients with cardiometabolic diseases caused by lipid disorders in the United States and internationally. The Company's drug pipeline consists of volanesorsen, AKCEA … Akcea Therapeutics Announces New Appointments to its Board ...

Nov 07, 2019 · All Akcea Therapeutics Inc. historial stock quotes by MarketWatch. View historical AKCA stock price data to see stock performance over time.

Mar 27, 2020 · Stock quote for Akcea Therapeutics, Inc. Common Stock Common Stock (AKCA) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. Buy shares of Akcea Therapeutics Inc (AKCA) stock - Stash

Akcea Therapeutics, Inc. engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing

AKCA | Complete Akcea Therapeutics Inc. stock news by MarketWatch. View real -time stock prices and stock quotes for a full financial overview. Get today's Akcea Therapeutics Inc stock price and latest AKCA news as well as Akcea Therapeutics real-time stock quotes, technical analysis, full financials  Get breaking news and analysis on Akcea Therapeutics, Inc. (AKCA) stock, price quote and chart, trading and investing tools. Akcea Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing drugs to treat patients with serious 

Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious 

Oct 07, 2019 · Shares of Akcea Therapeutics - Get Report jumped more than 30% Monday after the biotech company announced a licensing agreement with Pfizer - … Akcea Therapeutics (NasdaqGS:AKCA) - Share price, News ... Akcea Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing drugs to treat patients with serious and rare diseases in the United States and internationally. The company offers TEGSEDI, which is designed to reduce the production of transthyretin protein.

Real-time trade and investing ideas on Akcea Therapeutics, Inc AKCA from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Akcea Therapeutics | Crunchbase Oct 04, 2017 · Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc., is a development and commercialization company focused on transforming serious cardiometabolic lipid disorders. Akcea's portfolio spans multiple targets and disease states, including both rare and more common lipid disorders, using advanced RNA-targeted antisense therapeutics. Akcea Therapeutics - Stock Price History | AKCA | MacroTrends Historical daily share price chart and data for Akcea Therapeutics since 2020 adjusted for splits. The latest closing stock price for Akcea Therapeutics as of March 27, 2020 is 13.31.. The all-time high Akcea Therapeutics stock closing price was 38.99 on August 07, 2018.; The Akcea Therapeutics 52-week high stock price is 32.57, which is 144.7% above the current share price.